CT053PTSA
PCD-DCT053-17-001
Phase 2 small_molecule terminated
Quick answer
CT053PTSA for Renal Cell Cancer Metastatic is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Renal Cell Cancer Metastatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated